Also categorized in BoardMoves:
What Lies Ahead For Chesapeake As McClendon Exits?
x hide permanently

Verrica Pharmaceuticals Announces Dr. Lawrence Eichenfield Joins Board of Directors


WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, recently announced that Dr. Lawrence Eichenfield, Chief of Pediatric and Adolescent Dermatology, Rady Children’s Hospital, San Diego, CA...

Mentions: Nasdaq Lawrence Eichenfield Verrica Pharmaceuticals